Synapse - Christopher Azzoli

Results (19)

The SELECT trial: A multicenter phase II trial of adjuvant erlotinib (E) in patients with resected, early-stage non-small cell lung cancer (NSCLC) and confirmed mutations in the epidermal growth factor receptor (EGFR)

Meeting Abstract

Pennell, N. A.; Neal, J. W.; Govindan, R.; Janne, P. A.; Evans, T. L.; Costa, D. B.; Rosovsky, R. P. G.; Lanuti, M.; Azzoli, C. G.; Sequist, L. V.
Journal of Clinical Oncology (2011)

Fulltext@MSK | Save

Maintained sensitivity to EGFR tyrosine kinase inhibitors (TKIs) in EGFR-mutant lung cancers that recur after adjuvant TKI

Meeting Abstract

Oxnard, G. R.; Janjigian, Y. Y.; Arcila, M. E.; Kris, M. G.; Ladanyi, M.; Azzoli, C. G.; Miller, V. A.
Journal of Clinical Oncology (2011)

Fulltext@MSK | Save

Results of a randomized phase IIb study estimating overall survival of pralatrexate versus erlotinib in platinum-pretreated NSCLC

Meeting Abstract

Patel, J. D.; Azzoli, C. G.; Weems, G. A.; Koutsoukos, A.; Zatloukal, P.; Kelly, K.
Journal of Clinical Oncology (2011)

Fulltext@MSK | Save

Immunogenicity of GI-4000 vaccine in adjuvant consolidation therapy following definitive treatment in patients with stage I-III adenocarcinoma of the lung with G12C, G12D, or G12V KRAS mutations

Meeting Abstract

D'Angelo, S. P.; Park, B. J.; Krug, L. M.; Crevar, C.; Medina, C. E.; Sumner, D. K.; Richman, J.; Coeshott, C.; Apelian, D.; Cohn, A.; more...
Journal of Clinical Oncology (2011)

Fulltext@MSK | Save

A phase 2 study of weekly albumin-bound paclitaxel (Abraxane ®) given as a two-hour infusion

Journal Article

Paik, P. K.; James, L. P.; Riely, G. J.; Azzoli, C. G.; Miller, V. A.; Ng, K. K.; Sima, C. S.; Heelan, R. T.; Kris, M. G.; Moore, E.; more...
Cancer Chemotherapy and Pharmacology (2011)

Fulltext@MSK | Save

Pralatrexate with vitamin supplementation in patients with previously treated, advanced non-small cell lung cancer: Safety and efficacy in a phase 1 trial

Journal Article

Azzoli, C. G.; Patel, J. D.; Krug, L. M.; Miller, V.; James, L.; Kris, M. G.; Ginsberg, M.; Subzwari, S.; Tyson, L.; Dunne, M.; more...
Journal of Thoracic Oncology (2011)

Fulltext@MSK | Save

Maintained sensitivity to EGFR tyrosine kinase inhibitors in EGFR-mutant lung cancer recurring after adjuvant erlotinib or gefitinib

Journal Article

Oxnard, G. R.; Janjigian, Y. Y.; Arcila, M. E.; Sima, C. S.; Kass, S. L.; Riely, G. J.; Pao, W.; Kris, M. G.; Ladanyi, M.; Azzoli, C. G.; more...
Clinical Cancer Research (2011)

Fulltext@MSK | Save

2011 Focused update of 2009 American Society of Clinical Oncology clinical practice guideline update on chemotherapy for stage IV non-small-cell lung cancer